Detection of respiratory viruses in deceased persons, Spain, 2017

Emerging Infectious Diseases

Volumn 24, Issue 7, 2018, Pages 1331-1334

  Navascués, Ana ^a   Casado, Itziar ^b,c   Pérez García, Alejandra ^a,b   Aguinaga, Aitziber ^a   Martínez Baz, Iván ^b,c   Floristán, Yugo ^b,c   Ezpeleta, Carmen ^a   Castilla, Jesús ^b,c  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c IdiSNA Navarra Institute for Health Research   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; DEATH; DIAGNOSIS; FEMALE; HUMAN; HUMAN TISSUE; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; RESPIRATORY VIRUS; SEASON; SPAIN; AUTOPSY; HEALTH SURVEY; HISTORY; MORTALITY; RESPIRATORY TRACT INFECTION; VERY ELDERLY; VIROLOGY; VIRUS INFECTION;

AGED; AGED, 80 AND OVER; AUTOPSY; FEMALE; HISTORY, 21ST CENTURY; HUMANS; MALE; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; SPAIN; VIRUS DISEASES;

EID: 85050484750     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2407.180162     Document Type: Article

References (15)

1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179–86. http://dx.doi.org/10.1001/jama.289.2.179
2. Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017;22:30506. http://dx.doi.org/10.2807/1560-7917. ES.2017.22.14.30506
3. Bancroft EA, Lee S. Use of electronic death certificates for influenza death surveillance. Emerg Infect Dis. 2014;20:78–82. http://dx.doi.org/10.3201/eid2001.130471
4. Rizzo C, Bella A, Viboud C, Simonsen L, Miller MA, Rota MC, et al. Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969–2001. Emerg Infect Dis. 2007;13:694–9. http://dx.doi.org/10.3201/eid1305.061309
5. van Asten L, van den Wijngaard C, van Pelt W, van de Kassteele J, Meijer A, van der Hoek W, et al. Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons. J Infect Dis. 2012;206:628–39. http://dx.doi.org/10.1093/infdis/jis415
6. Casado I, Martínez-Baz I, Floristán Y, Chamorro J, Ezpeleta C, Castilla J; Network for Influenza Surveillance in Hospitals of Navarra. Cause of death in hospitalized patients with laboratory-confirmed influenza. An Sist Sanit Navar. 2015;38:263–8. http://dx.doi.org/10.4321/S1137-66272015000200010
7. Gilca R, Amini R, Douville-Fradet M, Charest H, Dubuque J, Boulianne N, et al. Other respiratory viruses are important contributors to adult respiratory hospitalizations and mortality even during peak weeks of the influenza season. Open Forum Infect Dis. 2014;1:ofu086. http://dx.doi.org/10.1093/ofid/ofu086
8. Moore C, Jones R. The use of coroner’s autopsy reports to validate the use of targeted swabbing rather than tissue collection for rapid confirmation of virological causes of sudden death in the community. J Clin Virol. 2015;63:59–62. http://dx.doi.org/10.1016/j.jcv.2014.11.031
9. Instituto de Salud Pública y Laboral de Navarra. Temporada de gripe 2016–2017 en Navarra. Boletín de Salud Pública de Navarra. No. 92; 2017 [cited 2018 May 8]. https://www.navarra.es/NR/rdonlyres/AECCD760-AB2A-4841-818A-FA53478FD6DC/387819/BOL9218.pdf
10. Kissling E, Rondy M; I-MOVE/I-MOVE+ study team. Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe. Euro Surveill. 2017;22:30464. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30464
11. Castilla J, Navascués A, Casado I, Díaz-González J, Pérez-García A, Fernandino L, et al.; Primary Health Care Sentinel Network and the Network for Influenza Surveillance in Hospitals of Navarre. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis. Euro Surveill. 2017;22:30465. http://dx.doi.org/10.2807/1560-7917.ES.2017.22.7.30465
12. Matias G, Taylor R, Haguinet F, Schuck-Paim C, Lustig R, Shinde V. Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses. 2014;8:507–15. http://dx.doi.org/10.1111/irv.12258
13. Speers DJ, Moss DM, Minney-Smith C, Levy A, Smith DW. Influenza and respiratory syncytial virus are the major respiratory viruses detected from prospective testing of pediatric and adult coronial autopsies. Influenza Other Respir Viruses. 2013;7: 1113–21. http://dx.doi.org/10.1111/irv.12139
14. Casado I, Domínguez Á, Toledo D, Chamorro J, Astray J, Egurrola M, et al.; Project PI12/02079 Working Group. Repeated influenza vaccination for preventing severe and fatal influenza infection in older adults: a multicentre case-control study. CMAJ. 2018;190:E3–12. http://dx.doi.org/10.1503/cmaj.170910
15. Ip DK, Lau LL, Leung NH, Fang VJ, Chan KH, Chu DK, et al. Viral shedding and transmission potential of asymptomatic and paucisymptomatic influenza virus infections in the community. Clin Infect Dis. 2017;64:736–42.